Hjem › Hypofarynxcancer › New Jersey › Edison
Kliniske studier for Hypofarynxcancer i Edison, NJ
4 studier for Hypofarynxcancer søker deltakere på steder i og rundt Edison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruttererFase 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RekruttererFase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RekruttererFase 2
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Hypofarynxcancer-studier i andre byer
- Atlanta, GA6 studier
- Chicago, IL6 studier
- Kansas City, MO5 studier
- Richmond, VA5 studier
- Wausau, WI5 studier
- Bloomington, IL5 studier
- Stevens Point, WI5 studier
- Cape Girardeau, MO5 studier
- Peoria, IL5 studier
- Milwaukee, WI5 studier
- Joliet, IL5 studier
- Overland Park, KS4 studier
Andre studier i Edison
- Brystkreft68 studier
- Ikke-småcellet lungekreft47 studier
- Kreft (alle typer)33 studier
- Prostatakreft29 studier
- Kolorektal kreft23 studier
- Lungekreft23 studier
- Multipelt myelom22 studier
- Blærekreft21 studier
- Akut myelogen leukemi20 studier
- Eggstokkreft20 studier
- Metastatisk kreft20 studier
- Endometriekreft19 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.